Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes
Irene Lurkin(Erasmus University Rotterdam), Ellen C. Zwarthoff(Erasmus MC), Margaret A. Knowles(St James's University Hospital), Robert Stoehr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Angela A.G. van Tilborg(Erasmus MC), Arndt Hartmann(Universitätsklinikum Erlangen), Carolyn D. Hurst(University of Leeds)
Cited by 94
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Intragenic ERBB2 kinase mutations in tumours
|Nature|2004|790
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381